Literature DB >> 9365894

Sequential analyses of the mutations in the core upstream and precore regions of hepatitis B virus genome in anti-HBe positive-carriers developing acute exacerbation.

A Nishizono1, K Kohno, Y Takita-Sonoda, M Hiraga, H Terao, T Fujioka, M Nasu, K Mifune.   

Abstract

The nucleotide sequences of the core upstream and precore regions (371 nucleotide length, nt. 1604-1974) of hepatitis B virus (HBV) were analysed sequentially in three subjects who were positive serologically for anti-HBe and had acute clinical exacerbation after immunosuppressive treatment. These patients were asymptomatic HBV carriers before therapy. The results revealed that the mutant with an 8-bp deletion (nt. 1768-1775) located in the basic core promoter region was dominant in the asymptomatic HBV carrier phase in two of three subjects. After exacerbation, however, such mutant clones possessing 8-bp deletion disappeared or decreased in number and were replaced by the clones possessing a precore stop codon mutation G to A (nt. 1896) or by the clones possessing additional contiguous point mutations A to T (nt. 1762) and G to A (nt. 1764) and a new point mutation C to T (nt. 1653). Possible relationships between acute exacerbation of liver function accompanied by mutation and the transition of the dominant clones were discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9365894

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  6 in total

1.  Preemptive use of lamivudine in breast cancer patients carrying hepatitis B virus undergoing cytotoxic chemotherapy: a longitudinal study.

Authors:  Meng-Shen Dai; Pei-Fen Wu; Jang-Jih Lu; Rong-Yaun Shyu; Tsu-Yi Chao
Journal:  Support Care Cancer       Date:  2004-03       Impact factor: 3.603

2.  Influence of hepatitis B virus X and core promoter mutations on hepatocellular carcinoma among patients infected with subgenotype C2.

Authors:  Noboru Shinkai; Yasuhito Tanaka; Kiyoaki Ito; Motokazu Mukaide; Izumi Hasegawa; Yasuhiro Asahina; Namiki Izumi; Hiroshi Yatsuhashi; Etsuro Orito; Takashi Joh; Masashi Mizokami
Journal:  J Clin Microbiol       Date:  2007-07-25       Impact factor: 5.948

3.  Hepatitis B virus genotypes and precore and core mutants in Brazilian patients.

Authors:  Roberta Sitnik; João Renato Rebello Pinho; Dennis Armando Bertolini; Antonio Plinio Bernardini; Luiz Caetano Da Silva; Flair José Carrilho
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

4.  Prophylactic Lamivudine to Improve the Outcome of Breast Cancer Patients With HBsAg Positive During Chemotherapy: A Meta-Analysis.

Authors:  Yihu Zheng; Shengchu Zhang; Hooi Min Tan Grahn; Chao Ye; Zheng Gong; Qiyu Zhang
Journal:  Hepat Mon       Date:  2013-04-01       Impact factor: 0.660

5.  The characteristic changes in hepatitis B virus x region for hepatocellular carcinoma: a comprehensive analysis based on global data.

Authors:  Wenwen Li; Kaku Goto; Yasuo Matsubara; Sayaka Ito; Ryosuke Muroyama; Qiang Li; Naoya Kato
Journal:  PLoS One       Date:  2015-05-05       Impact factor: 3.240

6.  Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis.

Authors:  Shijian Liu; Hongwei Zhang; Chunying Gu; Jianhua Yin; Yongchao He; Jiaxin Xie; Guangwen Cao
Journal:  J Natl Cancer Inst       Date:  2009-07-02       Impact factor: 13.506

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.